Discontinuation of statins in a population of older New Zealanders with limited life expectancy

Internal Medicine Journal

Volumn 46, Issue 4, 2016, Pages 493-496

  Nishtala, P S ^a   Gnjidic, D ^b   Chyou, T ^a   Hilmer, S N ^c  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b UNIVERSITY OF SYDNEY   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Cancer; Discontinuation; Older people; Primary prevention; Secondary prevention; Statins

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ARTICLE; CANCER DIAGNOSIS; CASE CONTROL STUDY; CHARLSON COMORBIDITY INDEX; DRUG WITHDRAWAL; HUMAN; LIFE EXPECTANCY; MALIGNANT NEOPLASTIC DISEASE; NEW ZEALAND; PRESCRIPTION; PRIORITY JOURNAL; PROPENSITY SCORE; SECONDARY PREVENTION; SOCIAL STATUS; TREATMENT WITHDRAWAL; AGED; COHORT ANALYSIS; FEMALE; MALE; MORTALITY; NEOPLASMS; PRIMARY PREVENTION; PROCEDURES; TRENDS; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LIFE EXPECTANCY; MALE; NEOPLASMS; PRIMARY PREVENTION; SECONDARY PREVENTION; WITHHOLDING TREATMENT;

EID: 84962856339     PISSN: 14440903     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/imj.13024     Document Type: Article

References (19)

1. Mangin D, Sweeney K, Heath I. Preventive health care in elderly people needs rethinking. BMJ 2007; 335: 285-7.
2. Hilmer SN, Gnjidic D. The effects of polypharmacy in older adults. Clin Pharmacol Ther 2009; 85: 86-88.
3. Ostini R, Hegney D, Jackson C, Tett SE. Knowing how to stop: ceasing prescribing when the medicine is no longer required. J Manag Care Pharm 2012; 18: 68-72.
4. Ostini R, Jackson C, Hegney D, Tett SE. How is medication prescribing ceased? A systematic review. Med Care 2011; 49: 24-36.
5. Scott IA, Gray LC, Martin JH, Pillans PI, Mitchell CA. Deciding when to stop: towards evidence-based deprescribing of drugs in older populations. Evid Based Med 2013; 18: 121-4.
6. Shepherd J, Cobbe SM, Ford I, Isles CG, Lorimer AR, MacFarlane PW et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. 1995. Atheroscler Suppl 2004; 5: 91-7.
7. Hilmer SN, Gnjidic D. Statins in older adults. Aust Prescr 2013; 36: 79-82.
8. Golomb BA. Implications of statin adverse effects in the elderly.Expert Opin Drug Saf 2005; 4:389-97.
9. Nishtala PS, Narayan SW, Wang T, Hilmer SN. Associations of drug burden index with falls, general practitioner visits, and mortality in older people. Pharmacoepidemiol Drug Saf 2014; 23: 753-8.
10. Holmes HM. Rational prescribing for patients with a reduced lifeexpectancy. Clin Pharmacol Ther 2009; 85: 103-7.
11. Sundararajan V, Henderson T, Perry C, Muggivan A, Quan H, Ghali WA. New ICD-10 version of the Charlson comorbidity index predicted in-hospital mortality. J Clin Epidemiol 2004; 57: 1288-94.
12. Sekhon JS. Multivariate and propensity score matching software with automated balance optimization: the matching package for R. J Stat Softw 2011; 42: 1-52.
13. Bayliss EA, Bronsert MR, Reifler LM, Ellis JL, Steiner JF, McQuillen DB et al. Statin prescribing patterns in a cohort of cancer patients with poor prognosis. J Palliat Med 2013; 16: 412-8.
14. Stavrou EP, Buckley N, Olivier J, Pearson S. Discontinuation of statin therapy in older people: does a cancer diagnosis make a difference? An observational cohort study using data linkage. BMJ Open 2012; 2: 1-6.
15. Tanvetyanon T, Choudhury AM. Physician practice in the discontinuation of statins among patients with advanced lung cancer. J Palliat Care 2006; 22: 281-5.
16. Laloux P. Risk and benefit of statins in stroke secondary prevention. Curr Vasc Pharmacol 2013; 11: 812-6.
17. Thomas JE, Tershakovec AM, Jones-Burton C, Sayeed RA, Foody JM. Lipid lowering for secondary prevention of cardiovascular disease in older adults. Drugs Aging 2010; 27: 959-72.
18. De Vera MA, Choi H, Abrahamowicz M, Kopec J, Lacaille D. Impact of statin discontinuation on mortality in patients with rheumatoid arthritis: a population-based study. Arthritis Care Res 2012; 64: 809-16.
19. Gill TM, Gahbauer EA, Han L, Allore HG. Trajectories of disability in the last year of life. N Engl J Med 2010; 362: 1173-80.